Cryosurgery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

The Cryosurgery Devices Market is expected to grow at a CAGR of over 6.5% during the forecast period.

COVID-19 had a significant impact on the growth of the market over the pandemic period. The demand for cryosurgery and cryotherapy was notably impacted to overcome the post-COVID symptoms among the infected patients. For instance, the article published by CPS published in January 2022, cryotherapy is an innovative treatment for post-COVID symptoms like loss of taste/smell, fatigue, and pain. The whole body cryotherapy among COVID-19-infected patients is used to reduce inflammation, improve blood flow, relieve pain, increase energy, and more. Thus, the benefits of cryotherapy and surgery devices during COVID-19 had a significant impact on the growth of the market during the pandemic period. In addition, the demand for cryosurgery devices is expected to remain impacted due to the increasing focus on treating various chronic diseases during the post-pandemic period over the forecast period.

The cryosurgery devices market is expected to register a boost in its growth rate due to increasing disorders, such as cardiovascular diseases and skin disorders. For instance, the British Heart Foundation (BHF) data published in January 2022 reported that in 2021, the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million) and atrial fibrillation (60 million). The report also mentioned that the prevalence of heart and circulatory diseases in North America was 46 million, in Europe 99 million, in Africa 58 million, in South America 32 million, and in Asia and Australia 310 million in 2021. For instance, as per the WHO data published in February 2022, in 2021, there were an estimated 1.9 million new cancer cases diagnosed in the United States. The report also mentioned that each year, approximately 400,000 children develop cancer globally. Cervical cancer is the most common in 23 countries, such as Eswatini, India, South Africa, Latin America, and others. The most common cancers are breast, lung, colon and rectum, and prostate cancers. Thus, the increasing prevalence of chronic disorders is expected to drive the demand for cryosurgery devices, thereby contributing to the growth of the market.

On the other hand, the increasing product launches by various key market players are also expected to drive the market's growth over the forecast period. For instance, in January 2021, Pregna International launched a CO-2-based cryotherapy device to help fight cervical cancer. This device was developed by Jhpiego for the treatment of cervical pre-cancerous lesions.

However, the stringent regulatory guidelines and reimbursement issues are expected to restrain the market's growth over the forecast period.

Cryosurgery Devices Market Trends

Pain Management Segment is Expected to Hold a Major Share in the Cryosurgery Devices Market

Cryosurgery devices are also used in pain management due to their high efficacy in reducing various chronic pains. The factors such as rising pain-related disorders such as musculoskeletal disorders, cancer pain, neuropathic pain, and others, along with increasing demand for minimally invasive surgery devices, are expected to drive the growth of the studied segment.

For instance, the data published by WHO in February 2021 reported that about 1.71 billion people have musculoskeletal conditions worldwide. Musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries. Among musculoskeletal disorders, low back pain causes the highest burden, with a prevalence of 568 million people annually. According to Work-Related Musculoskeletal Disorders statistics in Great Britain, in 2021, 470,000 people suffered from work-related musculoskeletal disorders, which are new or long-standing in the year 2020-2021. Additionally, the NCBI article published in February 2022, mentioned that the overall prevalence of neuropathic pain among the global population was between 7% and 10% in 2021. Such increasing prevalence of chronic diseases resulting in pain and pain-related disorders among the global population is expected to contribute to the demand for cryosurgery devices for effective treatment, thereby fueling segment growth.

Likewise, the innovative product approvals for the various key market players are also expected to drive segment growth. For instance, in January 2021, ArtiCure Inc. received US FDA clearance for additional labeling claims for cryo nerve block therapy to include the treatment of adolescent patients. The cryoICE and cryoSPHERE cryoablation probes are designed to temporarily block pain by ablating intercostal nerves under direct visualization in adolescent patients of at least 12 years of age.

Thus, the rising prevalence of pain-causing disorders, rising demand for minimally invasive surgeries, and increasing product approvals are expected to fuel segment growth.

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

North America is expected to hold a significant share of the studied market, owing to the increasing burden of chronic disorders and the presence of key market players with frequent product launches. The rising demand for minimally invasive surgery, along with advanced healthcare infrastructure in North America, is also expected to drive the market's growth over the forecast period in this region.

For instance, as per the 2022 Heart Disease and Stroke Statistics Update Fact Sheet, approximately every 40 seconds, a person in the United States is anticipated to have a myocardial infarction. Likewise, the CDC updated in September 2021 reported that approximately 6.5 million people aged 40 and older in the United States have the peripheral arterial disease. In addition, according to the Public Health Agency of Canada data published in October 2021, approximately 2 in 5 Canadians were diagnosed with Cancer in their lifetime. In 2021, an estimated 229,000 Canadians were diagnosed with Cancer. The report also mentioned that lung, breast, colorectal, and prostate cancers were expected to remain the most commonly diagnosed cancers, accounting for nearly 46% of all cancer diagnoses in 2021. Such a high prevalence of various chronic diseases among the North American population is expected to contribute to the rising demand for cryosurgery devices, in turn boosting the market growth.

Also, the increasing product launches by various key market players in this region are expected to drive the market's growth. For instance, in October 2022, PENTAX Medical launched the C2 CryoBallon ablation system for the treatment of Barrett's Esophagus in Canada. The C2 Croballon ablation system provides a significant economic advantage to hospitals, with minimal capital investment in treating pain-related disorders.

Thus, the increasing prevalence of chronic disorders, the presence of key market players along with frequent product launches are expected to contribute to the growth of the market in this region over the forecast period.

Cryosurgery Devices Market Competitor Analysis

The Cryosurgery Devices Market is moderately fragmented and competitive due to the presence of well-known market players. Some of the companies that are currently dominating the market are Harvard Bioscience Inc., AtriCure Inc., Brymill Cryogenic Systems, Cardinal Health, CryoConcepts, Cortex Technology, Bovie, and Cooper Surgical.

Additional benefits of purchasing the report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.